AC
IGTAR

Aristides Capital’s Inception Growth Acquisition Limited Rights IGTAR Stock Holding History

Aristides Capital’s Portfolio IGTAR Stock Details IGTAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$500 – 357
2024
Q4 		$500 Hold
10,000
– – ﹤0.01% 301
2024
Q3 		$1.2K Hold
10,000
– – ﹤0.01% 233
2024
Q2 		$1.5K Hold
10,000
– – ﹤0.01% 257
2024
Q1 		$1.97K Hold
10,000
– – ﹤0.01% 252
2023
Q4 		$1.31K Hold
10,000
– – ﹤0.01% 272
2023
Q3 		$1.8K Hold
10,000
– – ﹤0.01% 174
2023
Q2 		$1.7K Hold
10,000
– – ﹤0.01% 181
2023
Q1 		$988 Hold
10,000
– – ﹤0.01% 168
2022
Q4 		$990 Hold
10,000
– – ﹤0.01% 248
2022
Q3 		$1K Hold
10,000
– – ﹤0.01% 159
2022
Q2 		$1K Hold
10,000
– – ﹤0.01% 157
2022
Q1 		$2K Buy
+10,000
New +$1.74K ﹤0.01% 189

Other funds holding IGTAR

PL
Parkwood LLC Cleveland, Ohio $1.4B AUM 33.21% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Aristides Capital's IGTAR Position: Q1 2025 in Review

Aristides Capital sold out of Inception Growth Acquisition Limited Rights (IGTAR) in Q1 2025, closing a stake of 10,000 shares — an estimated $500 sold.

Aristides Capital first reported a position in IGTAR in Q1 2022 and held it in 12 quarters. The position peaked at $2K in Q1 2022. 2 funds tracked by Wall St. Rank hold IGTAR as of Q1 2025.

  • Aristides Capital reported no remaining Inception Growth Acquisition Limited Rights position as of Q1 2025 after selling out during the quarter.
  • Aristides Capital sold 10,000 Inception Growth Acquisition Limited Rights shares in Q1 2025, an estimated $500.
  • Aristides Capital first reported a position in Inception Growth Acquisition Limited Rights in Q1 2022 and held it in 12 quarters.
  • Aristides Capital's Inception Growth Acquisition Limited Rights position peaked at $2K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Inception Growth Acquisition Limited Rights as of Q1 2025.

Based on Aristides Capital's 13F filing for Q1 2025, filed 14 May 2025.